Kornelia Kotseva

Imperial Cardiac Health & Rehabilitation Service St. Marys & Charing Cross Hospitals, 5th Floor, 5 North, Room 27, Fulham Palace Road
London, ENG W68RF, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.

ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.

Journal: European heart journal

Published: July 30, 2026

EUROASPIRE 1996-2026: 30 years of research into prevention of cardiovascular disease.

EUROASPIRE 1996-2026: 30 years of research into prevention of cardiovascular disease.

Journal: European journal of preventive cardiology

Published: March 30, 2026

Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE study.

Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE study.

Journal: American journal of preventive cardiology

Published: March 02, 2026

Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.

Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.

Journal: International journal of cardiology

Published: February 16, 2026

Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study.

Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study.

Journal: Heart (British Cardiac Society)

Published: October 23, 2025

Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study.

Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study.

Journal: Journal of the American College of Cardiology

Published: October 17, 2025

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions.

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions.

Journal: European journal of cardiovascular nursing

Published: August 05, 2025

Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries.

Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries.

Journal: European journal of preventive cardiology

Published: August 04, 2025

Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease Results from the combined EUROASPIRE IV and V studies.

Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease Results from the combined EUROASPIRE IV and V studies.

Journal: European journal of preventive cardiology

Published: July 16, 2025

Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study.

Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study.

Journal: European journal of preventive cardiology

Published: July 15, 2025

Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.

Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.

Journal: European journal of preventive cardiology

Published: July 07, 2025

Residual cardiovascular risk is tracked by apolipoprotein B in coronary patients with elevated serum triglyceride levels: the ESC EORP EUROASPIRE IV survey.

Residual cardiovascular risk is tracked by apolipoprotein B in coronary patients with elevated serum triglyceride levels: the ESC EORP EUROASPIRE IV survey.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: May 25, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026